Edison, NJ, United States of America

Dong Ming Shen

This inventor holds 1 USPTO granted patent. Top assignees: Merck Sharp + Dohme Corp., Msd R&d (China) Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong Ming Shen. Retrieved from https://idiyas.com/inventor/dong-ming-shen-0lqqy2qi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dong Ming Shen

Introduction

Dong Ming Shen is an accomplished inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system disorders. His innovative work has led to the development of valuable therapeutic agents.

Latest Patents

Dong Ming Shen holds a patent for pyrimidone carboxamide compounds as PDE2 inhibitors. This patent discloses pyrimidine carboxamide compounds of formula (I), which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The pharmaceutical compositions and uses of these compounds represent a notable advancement in medical science.

Career Highlights

Throughout his career, Dong Ming Shen has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme Corporation and MSD R&D (China) Co., Ltd. His experience in these organizations has contributed to his expertise and innovative capabilities.

Collaborations

Dong Ming Shen has collaborated with notable professionals in his field, including Melissa S. Egbertson and Richard Berger. These collaborations have likely enhanced his research and development efforts.

Conclusion

Dong Ming Shen's contributions to the field of pharmaceuticals, particularly through his patent on PDE2 inhibitors, highlight his role as an innovative inventor. His work continues to impact the treatment of central nervous system disorders, showcasing the importance of research and development in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…